speb/financial-data huggingface dataset:
CS1.DE balance_sheet (annual, 2025-12-31) — Working Capital: 15000000.00
CS1.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 15000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 1211000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 4398000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 881000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 957000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -8978000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 13759000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 239900000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 4.83
CS1.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 696000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -711000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -707000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 51000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2220000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2220000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -141000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -192000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -601000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 2402000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 454000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1609000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 2000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -141000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 19546000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -66000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1586000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 391000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 4387000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 51000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Debt: 875000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 926000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 262000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 262000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3950000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 319000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 319000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 711000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 0.00
CS1.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 240759000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.81
CS1.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1159000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 255000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — EBIT: 1548000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — EBITDA: 2259000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 2305000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Financial Assets: 127000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -192000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1691000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 129000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: -1000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 63000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 33293000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 2812000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 429000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 3000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 59000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 59000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 100000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Interest Payable: 59000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 24554000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -601000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4133000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4133000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 703000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -66000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Net Debt: 2788000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Income: 1159000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1159000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1159000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1159000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1159000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1159000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1159000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -59000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 9000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
CS1.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -59000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 60000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 24315000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 37000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 19546000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 0.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 911000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 911000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
CS1.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2329000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 1213530000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2402000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 130000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Operating Income: 1601000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 4398000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 240085572.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 363000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 875000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 133000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Other Gand A: 63000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Other Income Expense: -53000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -381000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 692000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 278000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 17000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 27000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Payable: 1156000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Properties: 528000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 92000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Payables: 2183000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2574000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 55000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 1489000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 15000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -1000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Receivables: 1290000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -14000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1586000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 711000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -66000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 85000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 69000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 5785000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 10000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 41000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1121000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1184000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 240085572.00
CS1.DE income_statement (quarterly, 2026-03-31) — Special Income Charges: -70000000.00
CS1.DE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 10000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 19546000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 19546000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -15470000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 330000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 29521000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 23679000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 5059000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 19546000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 2797000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 9975000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 25134000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6025000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 1531000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 146000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -70000000.00
CS1.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -70000000.00
CS1.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: 437000000.00
CSAI income_statement (annual, 2022-12-31) — +Operating Expense: 11340000.00
CSAI income_statement (annual, 2022-12-31) — +Total Revenue: 489000.00
CSAI balance_sheet (annual, 2022-12-31) — Accounts Payable: 146000.00
CSAI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 301000.00
CSAI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 37453000.00
CSAI income_statement (annual, 2022-12-31) — Basic Average Shares: 14591554.00
CSAI income_statement (annual, 2022-12-31) — Basic EPS: -0.80
CSAI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 13647000.00
CSAI cash_flow (annual, 2022-12-31) — Capital Expenditure: -1805000.00
CSAI balance_sheet (annual, 2022-12-31) — Capital Stock: 9000.00
CSAI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 9414000.00
CSAI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 9414000.00
CSAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 8494000.00
CSAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1805000.00
CSAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -10923000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Account Payable: -250000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -312000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Interest Payable: -79000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -233000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 1000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Payable: -250000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -562000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Receivables: -8000.00
CSAI cash_flow (annual, 2022-12-31) — Change In Working Capital: -802000.00
CSAI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -8000.00
CSAI cash_flow (annual, 2022-12-31) — Changes In Cash: -4233000.00
CSAI balance_sheet (annual, 2022-12-31) — Common Stock: 9000.00
CSAI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 12148000.00
CSAI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 8663000.00
CSAI cash_flow (annual, 2022-12-31) — Common Stock Payments: -169000.00
CSAI income_statement (annual, 2022-12-31) — Cost Of Revenue: 774000.00
CSAI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: -20000.00
CSAI balance_sheet (annual, 2022-12-31) — Current Assets: 10361000.00
CSAI balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 53000.00
CSAI balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 53000.00
CSAI balance_sheet (annual, 2022-12-31) — Current Liabilities: 179000.00
CSAI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 196000.00
CSAI income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 196000.00
CSAI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 196000.00
CSAI income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 196000.00
CSAI income_statement (annual, 2022-12-31) — Depreciation Income Statement: 196000.00
CSAI income_statement (annual, 2022-12-31) — Diluted Average Shares: 14591554.00
CSAI income_statement (annual, 2022-12-31) — Diluted EPS: -0.80
CSAI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -11626000.00
CSAI income_statement (annual, 2022-12-31) — EBIT: -11616000.00
CSAI income_statement (annual, 2022-12-31) — EBITDA: -11420000.00
CSAI cash_flow (annual, 2022-12-31) — End Cash Position: 9414000.00
CSAI cash_flow (annual, 2022-12-31) — Financing Cash Flow: 8494000.00
CSAI cash_flow (annual, 2022-12-31) — Free Cash Flow: -12727000.00
CSAI income_statement (annual, 2022-12-31) — General And Administrative Expense: 3901000.00
CSAI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1674000.00
CSAI income_statement (annual, 2022-12-31) — Gross Profit: -286000.00
CSAI income_statement (annual, 2022-12-31) — Interest Expense: 10000.00
CSAI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 10000.00
CSAI balance_sheet (annual, 2022-12-31) — Inventory: 291000.00
CSAI balance_sheet (annual, 2022-12-31) — Invested Capital: 12148000.00
CSAI cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1805000.00
CSAI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 8663000.00
CSAI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 8494000.00
CSAI income_statement (annual, 2022-12-31) — Net Income: -11626000.00
CSAI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -11626000.00
CSAI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -11626000.00
CSAI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -11626000.00
CSAI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -11626000.00
CSAI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -11626000.00
CSAI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -11626000.00
CSAI cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1674000.00
CSAI income_statement (annual, 2022-12-31) — Net Interest Income: -10000.00
CSAI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -10000.00
CSAI balance_sheet (annual, 2022-12-31) — Net PPE: 291000.00
CSAI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -131000.00
CSAI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 10474000.00
CSAI income_statement (annual, 2022-12-31) — Normalized EBITDA: -11420000.00
CSAI income_statement (annual, 2022-12-31) — Normalized Income: -11626000.00
CSAI cash_flow (annual, 2022-12-31) — Operating Cash Flow: -10922000.00
CSAI income_statement (annual, 2022-12-31) — Operating Income: -11626000.00
CSAI income_statement (annual, 2022-12-31) — Operating Revenue: 489000.00
CSAI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 14591554.00
CSAI balance_sheet (annual, 2022-12-31) — Other Current Assets: 355000.00
CSAI income_statement (annual, 2022-12-31) — Other Gand A: 3901000.00
CSAI income_statement (annual, 2022-12-31) — Other Income Expense: 10000.00
CSAI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1000.00
CSAI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 10000.00
CSAI balance_sheet (annual, 2022-12-31) — Payables: 146000.00
CSAI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 126000.00
CSAI income_statement (annual, 2022-12-31) — Pretax Income: -11626000.00
CSAI cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1674000.00
CSAI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -131000.00
CSAI balance_sheet (annual, 2022-12-31) — Receivables: 301000.00
CSAI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 774000.00
CSAI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 196000.00
CSAI cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -169000.00
CSAI income_statement (annual, 2022-12-31) — Research And Development: 3663000.00
CSAI balance_sheet (annual, 2022-12-31) — Retained Earnings: -25314000.00
CSAI income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 3580000.00
CSAI income_statement (annual, 2022-12-31) — Selling General And Administration: 7481000.00
CSAI balance_sheet (annual, 2022-12-31) — Share Issued: 14591554.00
CSAI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1309000.00
CSAI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 12148000.00
CSAI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 10474000.00
CSAI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CSAI balance_sheet (annual, 2022-12-31) — Total Assets: 12326000.00
CSAI balance_sheet (annual, 2022-12-31) — Total Capitalization: 12148000.00
CSAI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 12148000.00
CSAI income_statement (annual, 2022-12-31) — Total Expenses: 12114000.00
CSAI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 178000.00
CSAI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1965000.00
CSAI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: -1000.00
CSAI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -11430000.00
CSAI balance_sheet (annual, 2022-12-31) — Working Capital: 10182000.00
CSAI income_statement (annual, 2023-12-31) — +Operating Expense: 8803000.00
CSAI income_statement (annual, 2023-12-31) — +Total Revenue: 607000.00
CSAI balance_sheet (annual, 2023-12-31) — Accounts Payable: 27000.00
CSAI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 351000.00
CSAI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 39001000.00
CSAI income_statement (annual, 2023-12-31) — Basic Average Shares: 14591554.00
CSAI income_statement (annual, 2023-12-31) — Basic EPS: -0.62
CSAI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 9414000.00
CSAI cash_flow (annual, 2023-12-31) — Capital Expenditure: -43000.00
CSAI balance_sheet (annual, 2023-12-31) — Capital Stock: 1000.00
CSAI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4042000.00
CSAI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 4042000.00
CSAI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 387000.00
CSAI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -43000.00
CSAI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -5717000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Account Payable: -119000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 69000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Interest Payable: 0.00
CSAI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1883000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
CSAI cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 144000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Payable: -119000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -50000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Receivables: -50000.00
CSAI cash_flow (annual, 2023-12-31) — Change In Working Capital: 1927000.00
CSAI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -50000.00
CSAI cash_flow (annual, 2023-12-31) — Changes In Cash: -5372000.00
CSAI balance_sheet (annual, 2023-12-31) — Common Stock: 1000.00
CSAI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 4681000.00
CSAI cash_flow (annual, 2023-12-31) — Common Stock Issuance: 387000.00
CSAI cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CSAI income_statement (annual, 2023-12-31) — Cost Of Revenue: 725000.00
CSAI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 48000.00
CSAI balance_sheet (annual, 2023-12-31) — Current Assets: 4830000.00
CSAI balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 197000.00
CSAI balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 197000.00
CSAI balance_sheet (annual, 2023-12-31) — Current Liabilities: 272000.00
CSAI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 209000.00
CSAI income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 209000.00
CSAI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 209000.00
CSAI income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 209000.00
CSAI income_statement (annual, 2023-12-31) — Depreciation Income Statement: 209000.00
CSAI income_statement (annual, 2023-12-31) — Diluted Average Shares: 14591554.00
CSAI income_statement (annual, 2023-12-31) — Diluted EPS: -0.62
CSAI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -9007000.00
CSAI income_statement (annual, 2023-12-31) — EBIT: -8921000.00
CSAI income_statement (annual, 2023-12-31) — EBITDA: -8712000.00
CSAI cash_flow (annual, 2023-12-31) — End Cash Position: 4042000.00
CSAI cash_flow (annual, 2023-12-31) — Financing Cash Flow: 387000.00
CSAI cash_flow (annual, 2023-12-31) — Free Cash Flow: -5759000.00
CSAI income_statement (annual, 2023-12-31) — General And Administrative Expense: 2365000.00
CSAI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
CSAI income_statement (annual, 2023-12-31) — Gross Profit: -118000.00
CSAI income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 1674000.00
CSAI income_statement (annual, 2023-12-31) — Interest Income: 55000.00
CSAI income_statement (annual, 2023-12-31) — Interest Income Non Operating: 55000.00
CSAI balance_sheet (annual, 2023-12-31) — Inventory: 315000.00
CSAI balance_sheet (annual, 2023-12-31) — Invested Capital: 4681000.00
CSAI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -43000.00
CSAI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 387000.00
CSAI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 387000.00
CSAI income_statement (annual, 2023-12-31) — Net Income: -9007000.00
CSAI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -9007000.00
CSAI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -9006000.00
CSAI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -9007000.00
CSAI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -9007000.00
CSAI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -9007000.00
CSAI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -9006000.00
CSAI cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
CSAI income_statement (annual, 2023-12-31) — Net Interest Income: 55000.00
CSAI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 55000.00
CSAI balance_sheet (annual, 2023-12-31) — Net PPE: 125000.00
CSAI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -43000.00
CSAI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4681000.00
CSAI income_statement (annual, 2023-12-31) — Normalized EBITDA: -8572000.00
CSAI income_statement (annual, 2023-12-31) — Normalized Income: -8867000.00
CSAI cash_flow (annual, 2023-12-31) — Operating Cash Flow: -5716000.00
CSAI income_statement (annual, 2023-12-31) — Operating Income: -8921000.00
CSAI income_statement (annual, 2023-12-31) — Operating Revenue: 607000.00
CSAI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 14591554.00
CSAI balance_sheet (annual, 2023-12-31) — Other Current Assets: 122000.00
CSAI income_statement (annual, 2023-12-31) — Other Gand A: 2365000.00
CSAI income_statement (annual, 2023-12-31) — Other Income Expense: -140000.00
CSAI cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1000.00
CSAI income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -140000.00
CSAI income_statement (annual, 2023-12-31) — Other Operating Expenses: 1674000.00
CSAI income_statement (annual, 2023-12-31) — Other Special Charges: 140000.00
CSAI income_statement (annual, 2023-12-31) — Other Taxes: 0.00
CSAI balance_sheet (annual, 2023-12-31) — Payables: 27000.00
CSAI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 75000.00
CSAI income_statement (annual, 2023-12-31) — Pretax Income: -9006000.00
CSAI cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
CSAI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -43000.00
CSAI balance_sheet (annual, 2023-12-31) — Receivables: 351000.00
CSAI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 725000.00
CSAI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 209000.00
CSAI cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CSAI income_statement (annual, 2023-12-31) — Research And Development: 2014000.00
CSAI balance_sheet (annual, 2023-12-31) — Retained Earnings: -34321000.00
CSAI income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 2541000.00
CSAI income_statement (annual, 2023-12-31) — Selling General And Administration: 4906000.00
CSAI balance_sheet (annual, 2023-12-31) — Share Issued: 14591554.00
CSAI income_statement (annual, 2023-12-31) — Special Income Charges: -140000.00
CSAI cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1154000.00
CSAI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4681000.00
CSAI balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4681000.00
CSAI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CSAI balance_sheet (annual, 2023-12-31) — Total Assets: 4954000.00
CSAI balance_sheet (annual, 2023-12-31) — Total Capitalization: 4681000.00
CSAI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 4681000.00
CSAI income_statement (annual, 2023-12-31) — Total Expenses: 9528000.00
CSAI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 273000.00
CSAI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 125000.00
CSAI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1000.00
CSAI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -8713000.00
CSAI income_statement (annual, 2023-12-31) — Total Unusual Items: -140000.00
CSAI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -140000.00
CSAI balance_sheet (annual, 2023-12-31) — Working Capital: 4558000.00
CSAI income_statement (quarterly, 2024-09-30) — Basic Average Shares: 14591554.00
CSAI income_statement (quarterly, 2024-09-30) — Basic EPS: -0.12
CSAI cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 7000.00
CSAI income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 14591554.00
CSAI income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.12
CSAI income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: -1000.00
CSAI balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 0.00
CSAI cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 6000.00
CSAI cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 7000.00
CSAI cash_flow (quarterly, 2024-09-30) — Net Intangibles Purchase And Sale: 0.00
CSAI cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
CSAI cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 3000.00
CSAI income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: -147000.00
CSAI cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 0.00
CSAI cash_flow (quarterly, 2024-09-30) — Purchase Of Intangibles: 0.00
CSAI cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 7000.00
CSAI income_statement (quarterly, 2024-09-30) — Total Unusual Items: -1000.00
CSAI income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -1000.00
CSAI income_statement (annual, 2024-12-31) — +Operating Expense: 6571000.00
CSAI income_statement (quarterly, 2024-12-31) — +Operating Expense: 1465000.00
CSAI income_statement (annual, 2024-12-31) — +Total Revenue: 1364000.00
CSAI income_statement (quarterly, 2024-12-31) — +Total Revenue: 440000.00
CSAI balance_sheet (annual, 2024-12-31) — Accounts Payable: 629000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 629000.00
CSAI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 196000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 196000.00
CSAI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 40351000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 40351000.00
CSAI income_statement (annual, 2024-12-31) — Basic Average Shares: 14591554.00
CSAI income_statement (annual, 2024-12-31) — Basic EPS: -0.45
CSAI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4042000.00
CSAI cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 444000.00
CSAI cash_flow (annual, 2024-12-31) — Capital Expenditure: -27000.00
CSAI cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -6000.00
CSAI balance_sheet (annual, 2024-12-31) — Capital Stock: 1000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1000.00
CSAI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 52000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 52000.00
CSAI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 52000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 52000.00
CSAI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -685000.00
CSAI cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -424000.00
CSAI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -27000.00
CSAI cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -6000.00
CSAI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -3277000.00
CSAI cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: 40000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Account Payable: 601000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Account Payable: 526000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -48000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: -45000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 151000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -18000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 0.00
CSAI cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 292000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 96000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Payable: 601000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Payable: 526000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 553000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 481000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Receivables: 155000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Receivables: -6000.00
CSAI cash_flow (annual, 2024-12-31) — Change In Working Capital: 1151000.00
CSAI cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 553000.00
CSAI cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 155000.00
CSAI cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -6000.00
CSAI cash_flow (annual, 2024-12-31) — Changes In Cash: -3990000.00
CSAI cash_flow (quarterly, 2024-12-31) — Changes In Cash: -392000.00
CSAI balance_sheet (annual, 2024-12-31) — Common Stock: 1000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Common Stock: 1000.00
CSAI balance_sheet (annual, 2024-12-31) — Common Stock Equity: -504000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -504000.00
CSAI cash_flow (annual, 2024-12-31) — Common Stock Issuance: 7000.00
CSAI income_statement (annual, 2024-12-31) — Cost Of Revenue: 990000.00
CSAI income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 222000.00
CSAI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 0.00
CSAI balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 0.00
CSAI balance_sheet (annual, 2024-12-31) — Current Assets: 535000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Current Assets: 535000.00
CSAI balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 489000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 489000.00
CSAI balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 489000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 489000.00
CSAI balance_sheet (annual, 2024-12-31) — Current Liabilities: 1118000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 1118000.00
CSAI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 72000.00
CSAI cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 17000.00
CSAI income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 72000.00
CSAI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 72000.00
CSAI cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 17000.00
CSAI income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 72000.00
CSAI income_statement (annual, 2024-12-31) — Depreciation Income Statement: 72000.00
CSAI income_statement (annual, 2024-12-31) — Diluted Average Shares: 14591554.00
CSAI income_statement (annual, 2024-12-31) — Diluted EPS: -0.45
CSAI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -1245000.00
CSAI balance_sheet (annual, 2024-12-31) — Dividends Payable: 0.00
CSAI balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 0.00
CSAI income_statement (annual, 2024-12-31) — EBIT: -6197000.00
CSAI income_statement (quarterly, 2024-12-31) — EBIT: -1247000.00
CSAI income_statement (annual, 2024-12-31) — EBITDA: -6125000.00
CSAI income_statement (quarterly, 2024-12-31) — EBITDA: -1230000.00
CSAI cash_flow (annual, 2024-12-31) — End Cash Position: 52000.00
CSAI cash_flow (quarterly, 2024-12-31) — End Cash Position: 52000.00
CSAI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -685000.00
CSAI cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -424000.00
CSAI cash_flow (annual, 2024-12-31) — Free Cash Flow: -3304000.00
CSAI cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 32000.00
CSAI balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CSAI balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CSAI income_statement (annual, 2024-12-31) — General And Administrative Expense: 1241000.00
CSAI income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 211000.00
CSAI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
CSAI balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
CSAI income_statement (annual, 2024-12-31) — Gross Profit: 374000.00
CSAI income_statement (quarterly, 2024-12-31) — Gross Profit: 218000.00
CSAI income_statement (annual, 2024-12-31) — Interest Income: 88000.00
CSAI income_statement (quarterly, 2024-12-31) — Interest Income: 2000.00
CSAI income_statement (annual, 2024-12-31) — Interest Income Non Operating: 88000.00
CSAI income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 2000.00
CSAI balance_sheet (annual, 2024-12-31) — Inventory: 249000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Inventory: 249000.00
CSAI balance_sheet (annual, 2024-12-31) — Invested Capital: -504000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Invested Capital: -504000.00
CSAI cash_flow (annual, 2024-12-31) — Investing Cash Flow: -27000.00
CSAI cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -6000.00
CSAI cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 7000.00
CSAI cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 7000.00
CSAI cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 51000.00
CSAI cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
CSAI income_statement (annual, 2024-12-31) — Net Income: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Income: -1245000.00
CSAI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -1245000.00
CSAI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -1245000.00
CSAI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1245000.00
CSAI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1245000.00
CSAI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -6535000.00
CSAI cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -1245000.00
CSAI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -1245000.00
CSAI cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CSAI cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CSAI income_statement (annual, 2024-12-31) — Net Interest Income: 88000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Interest Income: 2000.00
CSAI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 88000.00
CSAI income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 2000.00
CSAI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -692000.00
CSAI cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -475000.00
CSAI balance_sheet (annual, 2024-12-31) — Net PPE: 80000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Net PPE: 80000.00
CSAI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -27000.00
CSAI cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -6000.00
CSAI cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
CSAI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -504000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -504000.00
CSAI income_statement (annual, 2024-12-31) — Normalized EBITDA: -5699000.00
CSAI income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -1230000.00
CSAI income_statement (annual, 2024-12-31) — Normalized Income: -6109000.00
CSAI income_statement (quarterly, 2024-12-31) — Normalized Income: -1245000.00
CSAI cash_flow (annual, 2024-12-31) — Operating Cash Flow: -3277000.00
CSAI cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 38000.00
CSAI income_statement (annual, 2024-12-31) — Operating Income: -6197000.00
CSAI income_statement (quarterly, 2024-12-31) — Operating Income: -1247000.00
CSAI income_statement (annual, 2024-12-31) — Operating Revenue: 1364000.00
CSAI income_statement (quarterly, 2024-12-31) — Operating Revenue: 440000.00
CSAI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 14591554.00
CSAI balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 14591554.00
CSAI balance_sheet (annual, 2024-12-31) — Other Current Assets: 38000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 38000.00
CSAI income_statement (annual, 2024-12-31) — Other Gand A: 1241000.00
CSAI income_statement (quarterly, 2024-12-31) — Other Gand A: 211000.00
CSAI income_statement (annual, 2024-12-31) — Other Income Expense: -426000.00
CSAI income_statement (quarterly, 2024-12-31) — Other Income Expense: 0.00
CSAI income_statement (annual, 2024-12-31) — Other Operating Expenses: 2245000.00
CSAI income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 666000.00
CSAI income_statement (annual, 2024-12-31) — Other Special Charges: 426000.00
CSAI income_statement (annual, 2024-12-31) — Other Taxes: 6000.00
CSAI income_statement (quarterly, 2024-12-31) — Other Taxes: 4000.00
CSAI balance_sheet (annual, 2024-12-31) — Payables: 629000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Payables: 629000.00
CSAI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 629000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 629000.00
CSAI balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CSAI balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
CSAI cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
CSAI income_statement (annual, 2024-12-31) — Pretax Income: -6535000.00
CSAI income_statement (quarterly, 2024-12-31) — Pretax Income: -1245000.00
CSAI cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
CSAI cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
CSAI cash_flow (annual, 2024-12-31) — Purchase Of PPE: -27000.00
CSAI cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -6000.00
CSAI balance_sheet (annual, 2024-12-31) — Receivables: 196000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Receivables: 196000.00
CSAI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 990000.00
CSAI income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 222000.00
CSAI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 72000.00
CSAI income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 17000.00
CSAI income_statement (annual, 2024-12-31) — Research And Development: 1266000.00
CSAI income_statement (quarterly, 2024-12-31) — Research And Development: 220000.00
CSAI balance_sheet (annual, 2024-12-31) — Retained Earnings: -40856000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -40856000.00
CSAI income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1813000.00
CSAI income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 292000.00
CSAI income_statement (annual, 2024-12-31) — Selling General And Administration: 3054000.00
CSAI income_statement (quarterly, 2024-12-31) — Selling General And Administration: 503000.00
CSAI balance_sheet (annual, 2024-12-31) — Share Issued: 14591554.00
CSAI balance_sheet (quarterly, 2024-12-31) — Share Issued: 14591554.00
CSAI income_statement (annual, 2024-12-31) — Special Income Charges: -426000.00
CSAI cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2035000.00
CSAI cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 715000.00
CSAI balance_sheet (annual, 2024-12-31) — Stockholders Equity: -504000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -504000.00
CSAI balance_sheet (annual, 2024-12-31) — Tangible Book Value: -504000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -504000.00
CSAI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CSAI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CSAI income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
CSAI balance_sheet (annual, 2024-12-31) — Total Assets: 615000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Total Assets: 615000.00
CSAI balance_sheet (annual, 2024-12-31) — Total Capitalization: -504000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -504000.00
CSAI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -504000.00
CSAI balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -504000.00
CSAI income_statement (annual, 2024-12-31) — Total Expenses: 7561000.00
CSAI income_statement (quarterly, 2024-12-31) — Total Expenses: 1687000.00